Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
colorectal cancer survival
diet
evidence grading
food
systematic review
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 May 2024
01 May 2024
Historique:
revised:
15
12
2023
received:
21
07
2023
accepted:
17
01
2024
medline:
2
5
2024
pubmed:
2
5
2024
entrez:
1
5
2024
Statut:
aheadofprint
Résumé
The role of diet in colorectal cancer prognosis is not well understood and specific lifestyle recommendations are lacking. We searched for randomised controlled trials (RCTs) and longitudinal observational studies on post-diagnosis dietary factors, supplement use and colorectal cancer survival outcomes in PubMed and Embase from inception until 28th February 2022. Random-effects dose-response meta-analyses were conducted when at least three studies had sufficient information. The evidence was interpreted and graded by the CUP Global independent Expert Committee on Cancer Survivorship and Expert Panel. Five RCTs and 35 observational studies were included (30,242 cases, over 8700 all-cause and 2100 colorectal cancer deaths, 3700 progression, recurrence, or disease-free events). Meta-analyses, including 3-10 observational studies each, were conducted for: whole grains, nuts/peanuts, red and processed meat, dairy products, sugary drinks, artificially sweetened beverages, coffee, alcohol, dietary glycaemic load/index, insulin load/index, marine omega-3 polyunsaturated fatty acids, supplemental calcium, circulating 25-hydroxyvitamin D (25[OH]D) and all-cause mortality; for alcohol, supplemental calcium, circulating 25(OH)D and colorectal cancer-specific mortality; and for circulating 25(OH)D and recurrence/disease-free survival. The overall evidence was graded as 'limited'. The inverse associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant-based foods), whole grains, total, caffeinated, or decaffeinated coffee and all-cause mortality and the positive associations between unhealthy dietary patterns, sugary drinks and all-cause mortality provided 'limited-suggestive' evidence. All other exposure-outcome associations provided 'limited-no conclusion' evidence. Additional, well-conducted cohort studies and carefully designed RCTs are needed to develop specific lifestyle recommendations for colorectal cancer survivors.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : World Cancer Research Fund
Organisme : Wereld Kanker Onderzoek Fonds
Organisme : American Institute for Cancer Research
Informations de copyright
© 2024 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338‐344.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209‐249.
Ferlay JEM, Lam F, Colombet M, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2020.
Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi RE, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68:7‐11.
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174.
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000‐14 (CONCORD‐3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population‐based registries in 71 countries. Lancet. 2018;391:1023‐1075.
Gullickson C, Goodman M, Joko‐Fru YW, et al. Colorectal cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: a population‐based registry study. Int J Cancer. 2021;149:1553‐1563.
Soerjomataram I, Cabasag C, Bardot A, et al. Cancer survival in Africa, central and south America, and Asia (SURVCAN‐3): a population‐based benchmarking study in 32 countries. Lancet Oncol. 2023;24:22‐32.
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. Jama. 2021;325:1978‐1998.
Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. Jama. 2016;315:2576‐2594.
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467‐1480.
Jiang Y, Yuan H, Li Z, et al. Global pattern and trends of colorectal cancer survival: a systematic review of population‐based registration data. Cancer Biol Med. 2021;19:175‐186.
Anderson AS, Martin RM, Renehan AG, et al. Cancer survivorship, excess body fatness and weight‐loss intervention‐where are we in 2020? Br J Cancer. 2021;124:1057‐1065.
Feng Y, Jin H, Guo K, Wasan HS, Ruan S, Chen C. Causes of death after colorectal cancer diagnosis: a population‐based study. Front Oncol. 2021;11:647179.
Fuccio L, Rex D, Ponchon T, et al. New and recurrent colorectal cancers after resection: a systematic review and meta‐analysis of endoscopic surveillance studies. Gastroenterology. 2019;156:1309‐1323.e3.
Guraya SY. Pattern, stage, and time of recurrent colorectal cancer after curative surgery. Clin Colorectal Cancer. 2019;18:e223‐e228.
Du S, Li Y, Sun H, et al. The risk of developing second primary malignancies among colorectal cancer patients. Aging (Albany NY). 2022;14:6756‐6779.
Jia H, Li Q, Yuan J, Sun X, Wu Z. Second primary malignancies in patients with colorectal cancer: a population‐based analysis. Oncologist. 2020;25:e644‐e650.
World Cancer Research Fund International/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. Continuous Update Project Expert Report. 2018. Accessed March 2023. http://dietandcancerreport.org
Papadimitriou N, Markozannes G, Kanellopoulou A, et al. An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 2021;12:4579.
Rock CL, Thomson CA, Sullivan KR, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. 2022;72:230‐262.
Zhong Y, Zhu Y, Li Q, et al. Association between Mediterranean diet adherence and colorectal cancer: a dose–response meta‐analysis. Am J Clin Nutr. 2020;111:1214‐1225.
Hoang T, Kim H, Kim J. Dietary intake in association with all‐cause mortality and colorectal cancer mortality among colorectal cancer survivors: a systematic review and meta‐analysis of prospective studies. Cancers (Basel). 2020;12:3391.
Kim Y, Je Y, Giovannucci EL. Association between alcohol consumption and survival in colorectal cancer: a meta‐analysis. Cancer Epidemiol Biomarkers Prev. 2019;28:1891‐1901.
Kanellopoulou A, Riza E, Samoli E, Benetou V. Dietary supplement use after cancer diagnosis in relation to total mortality, cancer mortality and recurrence: a systematic review and meta‐analysis. Nutr Cancer. 2021;73:16‐30.
Wu G, Xue M, Zhao Y, et al. Low circulating 25‐hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose‐response meta‐analysis. Biosci Rep. 2020;40:BSR20201008.
Vaughan‐Shaw PG, Buijs LF, Blackmur JP, et al. The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta‐analysis of randomised controlled trials. Br J Cancer. 2020;123:1705‐1712.
Global Cancer Update Programme (CUP Global). Accessed March 2023. https://www.wcrf.org/diet-activity-and-cancer/global-cancer-update-programme/about-the-global-cancer-update-programme
Becerra‐Tomás N, Markozannes G, Cariolou M, et al. Post‐diagnosis adiposity and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis. Int J Cancer. 2024.
Markozannes G, Becerra‐Tomás N, Cariolou M, et al. Post‐diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis. Int J Cancer. 2024.
Tsilidis KK, Markozannes G, Becerra‐Tomás N, et al. Post‐diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading. Int J Cancer. 2024.
Chan DSM, Tsilidis K, Becerra‐Tomas N, et al. Global Cancer Update Programme Protocol for the data collection and systematic literature review on the role of diet, body fatness and physical activity on survival after colorectal cancer. 2022. Accessed March 2023. https://osf.io/r5ud2/registrations
Lewis C, Xun P, He K. Vitamin D supplementation and quality of life following diagnosis in stage II colorectal cancer patients: a 24‐month prospective study. Support Care Cancer. 2016;24:1655‐1661.
Geijsen A, Ulvik A, Gigic B, et al. Circulating folate and folic acid concentrations: associations with colorectal cancer recurrence and survival. JNCI Cancer Spectr. 2020;4:pkaa051.
Wesselink E, Kok DE, Bours MJL, et al. Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all‐cause mortality. Am J Clin Nutr. 2020;111:1007‐1017.
Wesa KM, Segal NH, Cronin AM, et al. Serum 25‐hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis. Nutr Cancer. 2015;67:424‐430.
Abrahamsson H, Meltzer S, Hagen VN, et al. Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer. BMC Cancer. 2021;21:535.
FDA. Dietary Supplements. 2023. Accessed July 2023. https://www.fda.gov/food/dietary-supplements/dietary-supplement-ingredient-directory
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Control Clin Trials. 1986;7:177‐188.
Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:79.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Stat Med. 2002;21:1539‐1558.
Borenstein M, Higgins JP, Hedges LV, Rothstein HR. Basics of meta‐analysis: I(2) is not an absolute measure of heterogeneity. Res Synth Methods. 2017;8:5‐18.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ. 1997;315:629‐634.
Orsini N. Weighted mixed‐effects dose–response models for tables of correlated contrasts. Stata J. 2021;21:320‐347.
Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med. 2000;19:1831‐1847.
Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta‐analysis. Res Synth Methods. 2010;1:112‐125.
Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
USDA. Nutrition Evidence Systematic Review. Risk of Bias for Nutrition Observational Studies (RoB‐NObs) Tool. Accessed November 2022. https://nesr.usda.gov/sites/default/files/2019‐07/RiskOfBiasForrNutritionObservationalStudies‐RoB‐NObs.pdf
Sterne JA, Hernan MA, Reeves BC, et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ. 2016;355:i4919.
Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst. 2013;105:1456‐1462.
van Zutphen M, van Duijnhoven FJB, Wesselink E, et al. Identification of lifestyle behaviors associated with recurrence and survival in colorectal cancer patients using random survival forests. Cancers (Basel). 2021;13:2442.
Cheng E, Ou FS, Ma C, et al. Diet‐ and lifestyle‐based prediction models to estimate cancer recurrence and death in patients with stage III colon cancer (CALGB 89803/Alliance). J Clin Oncol. 2022;40:740‐751.
Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25‐hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population‐based study. Cancer Causes Control. 2012;23:363‐370.
Yuan C, Renfro L, Ambadwar PB, et al. Influence of genetic variation in the vitamin D pathway on plasma 25‐hydroxyvitamin D(3) levels and survival among patients with metastatic colorectal cancer. Cancer Causes Control. 2019;30:757‐765.
Zgaga L, Theodoratou E, Farrington SM, et al. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol. 2014;32:2430‐2439.
Keum N, Yuan C, Nishihara R, et al. Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer. 2017;140:2648‐2656.
Hamada T, Liu L, Nowak JA, et al. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. Eur J Cancer. 2018;103:98‐107.
Fuchs MA, Yuan C, Sato K, et al. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol. 2017;28:1359‐1367.
Ng K, Wolpin BM, Meyerhardt JA, et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009;101:916‐923.
Wesselink E, Staritsky LE, van Zutphen M, et al. The association between the adapted dietary inflammatory index and colorectal cancer recurrence and all‐cause mortality. Clin Nutr. 2021;40:4436‐4443.
Zheng J, Tabung FK, Zhang J, et al. Post‐cancer diagnosis dietary inflammatory potential is associated with survival among women diagnosed with colorectal cancer in the Women's Health Initiative. Eur J Nutr. 2020;59:965‐977.
Ratjen I, Shivappa N, Schafmayer C, et al. Association between the dietary inflammatory index and all‐cause mortality in colorectal cancer long‐term survivors. Int J Cancer. 2019;144:1292‐1301.
Sawayama H, Miyamoto Y, Mima K, et al. Preoperative iron status is a prognosis factor for stage II and III colorectal cancer. Int J Clin Oncol. 2021;26:2037‐2045.
Yang M, Zhang Q, Ruan GT, et al. Association between serum creatinine concentrations and overall survival in patients with colorectal cancer: a multi‐center cohort study. Front Oncol. 2021;11:710423.
Long L, Yang W, Liu L, et al. Dietary intake of branched‐chain amino acids and survival after colorectal cancer diagnosis. Int J Cancer. 2020;148:2471‐2480.
Jiang R, Poschet G, Owen R, et al. Serum concentration of genistein, luteolin and colorectal cancer prognosis. Nutrients. 2019;11:600.
Delphan M, Lin T, Liesenfeld DB, et al. Associations of branched‐chain amino acids with parameters of energy balance and survival in colorectal cancer patients: results from the ColoCare study. Metabolomics. 2018;2018:22.
Maalmi H, Walter V, Jansen L, et al. Dose‐response relationship between serum retinol levels and survival in patients with colorectal cancer: results from the DACHS study. Nutrients. 2018;10:510.
Lee S, Song A, Eo W. Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer. J Cancer. 2016;7:957‐964.
Psathakis D, Wedemeyer N, Oevermann E, Krug F, Siegers CP, Bruch HP. Blood selenium and glutathione peroxidase status in patients with colorectal cancer. Dis Colon Rectum. 1998;41:328‐335.
Wang Y, Liu P, Fang Y, et al. The effect of Long‐term traditional Chinese medicine treatment on survival time of colorectal cancer based on propensity score matching: a retrospective cohort study. Evid Based Complement Alternat Med. 2020;2020:7023420.
Zhang M, Zhao QC, Liu YP, Yang L, Zhu HM, Chhetri JK. Prognostic analysis and comparison of colon cancer in Han and Hui patients. World J Gastroenterol. 2014;20:5082‐5086.
Kuo YT, Liao CK, Chen TC, Lai CC, Chiang SF, Chiang JM. A high density of PD‐L1‐expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer. Medicine (Baltimore). 2022;101:e28573.
Sorensen LS, Rasmussen SL, Calder PC, Yilmaz MN, Schmidt EB, Thorlacius‐Ussing O. Long‐term outcomes after perioperative treatment with omega‐3 fatty acid supplements in colorectal cancer. BJS Open. 2020;4:678‐684.
Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High‐dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double‐blind comparison. N Engl J Med. 1985;312:137‐141.
Ng K, Nimeiri HS, McCleary NJ, et al. Effect of high‐dose vs standard‐dose vitamin D3 supplementation on progression‐free survival among patients with advanced or metastatic colorectal cancer: the SUNSHINE randomized clinical trial. Jama. 2019;321:1370‐1379.
Brown JC, Rosenthal MH, Ma C, et al. Effect of high‐dose vs standard‐dose vitamin D(3) supplementation on body composition among patients with advanced or metastatic colorectal cancer: a randomized trial. Cancers (Basel). 2020;12:3451.
Urashima M, Ohdaira H, Akutsu T, et al. Effect of vitamin D supplementation on relapse‐free survival among patients with digestive tract cancers: the AMATERASU randomized clinical trial. Jama. 2019;321:1361‐1369.
Ravasco P, Monteiro‐Grillo I, Camilo M. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long‐term follow‐up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr. 2012;96:1346‐1353.
Song R, Petimar J, Wang M, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2021;30:1816‐1825.
van Zutphen M, Boshuizen HC, Kenkhuis MF, et al. Lifestyle after colorectal cancer diagnosis in relation to recurrence and all‐cause mortality. Am J Clin Nutr. 2021;113:1447‐1457.
Cheng E, Zhang S, Ou FS, et al. The diet of higher insulinemic potential is not associated with worse survival in patients with stage III colon cancer (Alliance). Cancer Epidemiol Biomarkers Prev. 2020;29:1692‐1695.
Tabung FK, Noonan A, Lee DH, et al. Post‐diagnosis dietary insulinemic potential and survival outcomes among colorectal cancer patients. BMC Cancer. 2020;20:817.
Van Blarigan EL, Zhang S, Ou FS, et al. Association of diet quality with survival among people with metastatic colorectal cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial. JAMA Netw Open. 2020;3:e2023500.
Guinter MA, McCullough ML, Gapstur SM, Campbell PT. Associations of pre‐ and postdiagnosis diet quality with risk of mortality among men and women with colorectal cancer. J Clin Oncol. 2018;36:JCO1800714.
Van Blarigan EL, Fuchs CS, Niedzwiecki D, et al. Association of Survival with Adherence to the American Cancer Society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis: the CALGB 89803/Alliance trial. JAMA Oncol. 2018;4:783‐790.
Liu L, Nishihara R, Qian ZR, et al. Association between inflammatory diet pattern and risk of colorectal carcinoma subtypes classified by immune responses to tumor. Gastroenterology. 2017;153:1517‐1530. e14.
Ratjen I, Schafmayer C, di Giuseppe R, et al. Postdiagnostic Mediterranean and healthy Nordic dietary patterns are inversely associated with all‐cause mortality in long‐term colorectal cancer survivors. J Nutr. 2017;147:636‐644.
Fung TT, Kashambwa R, Sato K, et al. Post diagnosis diet quality and colorectal cancer survival in women. PLoS One. 2014;9:e115377.
Inoue‐Choi M, Robien K, Lazovich D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer Epidemiol Biomarkers Prev. 2013;22:792‐802.
Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. Jama. 2007;298:754‐764.
Ratjen I, Enderle J, Burmeister G, et al. Post‐diagnostic reliance on plant‐compared with animal‐based foods and all‐cause mortality in omnivorous long‐term colorectal cancer survivors. Am J Clin Nutr. 2021;114:441‐449.
Brown JC, Zhang S, Niedzwiecki D, et al. Grain intake and clinical outcome in stage III colon cancer: results from CALGB 89803 (Alliance). JNCI Cancer Spectr. 2018;2:pky017.
Song M, Wu K, Meyerhardt JA, et al. Fiber intake and survival after colorectal cancer diagnosis. JAMA Oncol. 2018;4:71‐79.
Tamakoshi A, Nakamura K, Ukawa S, et al. Characteristics and prognosis of Japanese colorectal cancer patients: the BioBank Japan Project. J Epidemiol. 2017;27:S36‐S42.
Fadelu T, Zhang S, Niedzwiecki D, et al. Nut consumption and survival in patients with stage III colon cancer: results from CALGB 89803 (Alliance). J Clin Oncol. 2018;36:1112‐1120.
Van Blarigan EL, Ou FS, Bainter TM, et al. Associations between unprocessed red meat and processed meat with risk of recurrence and mortality in patients with stage III colon cancer. JAMA Netw Open. 2022;5:e220145.
McCullough ML, Gapstur SM, Shah R, Jacobs EJ, Campbell PT. Association between red and processed meat intake and mortality among colorectal cancer survivors. J Clin Oncol. 2013;31:2773‐2782.
Song M, Ou FS, Zemla TJ, et al. Marine omega‐3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG phase III trial N0147 (Alliance). Int J Cancer. 2019;145:380‐389.
Van Blarigan EL, Fuchs CS, Niedzwiecki D, et al. Marine omega‐3 polyunsaturated fatty acid and fish intake after colon cancer diagnosis and survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018;27:438‐445.
Liu X, Yang W, Wu K, et al. Postdiagnostic dairy products intake and colorectal cancer survival in US males and females. Am J Clin Nutr. 2021;113:1636‐1646.
Yang B, McCullough ML, Gapstur SM, et al. Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: the cancer prevention study‐II nutrition cohort. J Clin Oncol. 2014;32:2335‐2343.
Fuchs MA, Sato K, Niedzwiecki D, et al. Sugar‐sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance). PLoS One. 2014;9:e99816.
Zoltick ES, Smith‐Warner SA, Yuan C, et al. Sugar‐sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival. Br J Cancer. 2021;125:1016‐1024.
Guercio BJ, Zhang S, Niedzwiecki D, et al. Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: results from CALGB 89803 (Alliance). PLoS One. 2018;13:e0199244.
Ugai T, Haruki K, Vayrynen JP, et al. Coffee intake of colorectal cancer patients and prognosis according to histopathologic lymphocytic reaction and T‐cell infiltrates. Mayo Clin Proc. 2022;97:124‐133.
Mackintosh C, Yuan C, Ou FS, et al. Association of coffee intake with survival in patients with advanced or metastatic colorectal cancer. JAMA Oncol. 2020;6:1713‐1721.
Hu Y, Ding M, Yuan C, et al. Association between coffee intake after diagnosis of colorectal cancer and reduced mortality. Gastroenterology. 2018;154:916‐926.e9.
Guercio BJ, Sato K, Niedzwiecki D, et al. Coffee intake, recurrence, and mortality in stage III colon cancer: results from CALGB 89803 (Alliance). J Clin Oncol. 2015;33:3598‐3607.
Yang B, Gapstur SM, Newton CC, Jacobs EJ, Campbell PT. Alcohol intake and mortality among survivors of colorectal cancer: the cancer prevention study II nutrition cohort. Cancer. 2017;123:2006‐2013.
Lochhead P, Nishihara R, Qian ZR, et al. Postdiagnostic intake of one‐carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin Nutr. 2015;102:1134‐1141.
Atinafu BT, Bulti FA, Demelew TM. Survival status and predictors of mortality among colorectal cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective followup study. J Cancer Prev. 2020;25:38‐47.
Maeda M, Nagawa H, Maeda T, Koike H, Kasai H. Alcohol consumption enhances liver metastasis in colorectal carcinoma patients. Cancer. 1998;83:1483‐1488.
Ramjeesingh R, Orr C, Bricks CS, Hopman WM, Hammad N. A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival. Curr Oncol. 2016;23:e116‐e122.
Song M, Wu K, Meyerhardt JA, et al. Low‐carbohydrate diet score and macronutrient intake in relation to survival after colorectal cancer diagnosis. JNCI Cancer Spectr. 2018;2:pky077.
Meyerhardt JA, Sato K, Niedzwiecki D, et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012;104:1702‐1711.
Yuan C, Bao Y, Sato K, et al. Influence of dietary insulin scores on survival in colorectal cancer patients. Br J Cancer. 2017;117:1079‐1087.
Morales‐Oyarvide V, Yuan C, Babic A, et al. Dietary insulin load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803 (Alliance). J Natl Cancer Inst. 2019;111:170‐179.
Van Blarigan EL, Ou FS, Niedzwiecki D, et al. Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018;27:1227‐1230.
Song M, Zhang X, Meyerhardt JA, et al. Marine omega‐3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis. Gut. 2017;66:1790‐1796.
Inoue‐Choi M, Greenlee H, Oppeneer SJ, Robien K. The association between postdiagnosis dietary supplement use and total mortality differs by diet quality among older female cancer survivors. Cancer Epidemiol Biomarkers Prev. 2014;23:865‐875.
Abdel‐Rahman O, Spratlin J, Koski S. Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials. J Cancer Res Clin Oncol. 2020;146:2089‐2097.
Ng K, Meyerhardt JA, Chan JA, et al. Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2010;28:4354‐4363.
Yang W, Ma Y, Smith‐Warner S, et al. Calcium intake and survival after colorectal cancer diagnosis. Clin Cancer Res. 2019;25:1980‐1988.
Boakye D, Jansen L, Schottker B, et al. The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity. Am J Clin Nutr. 2021;113:1458‐1467.
Kim J, Baek DW, Baek JH, et al. Clinical impact of postoperative vitamin D deficiency on the recurrence of colon cancer after curative surgical resection. Anticancer Res. 2021;41:3683‐3688.
Sinicrope FA, Shi Q, Smyrk TC, et al. Association of adiponectin and vitamin D with tumor infiltrating lymphocytes and survival in stage III colon cancer. JNCI Cancer Spectr. 2021;5:pkab070.
Wesselink E, Kok DE, de Wilt JHW, et al. Sufficient 25‐hydroxyvitamin D levels 2 years after colorectal cancer diagnosis are associated with a lower risk of all‐cause mortality. Cancer Epidemiol Biomarkers Prev. 2021;30:765‐773.
Bao Y, Li Y, Gong Y, Huang Q, Cai S, Peng J. Vitamin D status and survival in stage II–III colorectal cancer. Front Oncol. 2020;10:581597.
Markotic A, Langer S, Kelava T, et al. Higher post‐operative serum vitamin D level is associated with better survival outcome in colorectal cancer patients. Nutr Cancer. 2019;71:1078‐1085.
Yuan C, Sato K, Hollis BW, et al. Plasma 25‐hydroxyvitamin D levels and survival in patients with advanced or metastatic colorectal cancer: findings from CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2019;25:7497‐7505.
Maalmi H, Walter V, Jansen L, et al. Relationship of very low serum 25‐hydroxyvitamin D(3) levels with long‐term survival in a large cohort of colorectal cancer patients from Germany. Eur J Epidemiol. 2017;32:961‐971.
Facciorusso A, Del Prete V, Muscatiello N, Crucinio N, Barone M. Prognostic role of 25‐hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation. J Gastroenterol Hepatol. 2016;31:1483‐1488.
Vaughan‐Shaw PG, Zgaga L, Ooi LY, et al. Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response. Gut. 2020;69:103‐111.
Cooney RV, Chai W, Franke AA, Wilkens LR, Kolonel LN, Le Marchand L. C‐reactive protein, lipid‐soluble micronutrients, and survival in colorectal cancer patients. Cancer Epidemiol Biomarkers Prev. 2013;22:1278‐1288.
Ng K, Sargent DJ, Goldberg RM, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup Trial N9741. J Clin Oncol. 2011;29:1599‐1606.
Mezawa H, Sugiura T, Watanabe M, et al. Serum vitamin D levels and survival of patients with colorectal cancer: post‐hoc analysis of a prospective cohort study. BMC Cancer. 2010;10:347.
Schulze MB, Martinez‐Gonzalez MA, Fung TT, Lichtenstein AH, Forouhi NG. Food based dietary patterns and chronic disease prevention. BMJ. 2018;361:k2396.
Wang P, Song M, Eliassen AH, et al. Optimal dietary patterns for prevention of chronic disease. Nat Med. 2023;29:719‐728.
Aleksandrova K, Koelman L, Rodrigues CE. Dietary patterns and biomarkers of oxidative stress and inflammation: a systematic review of observational and intervention studies. Redox Biol. 2021;42:101869.
Barbaresko J, Koch M, Schulze MB, Nothlings U. Dietary pattern analysis and biomarkers of low‐grade inflammation: a systematic literature review. Nutr Rev. 2013;71:511‐527.
English CJ, Mayr HL, Lohning AE, Reidlinger DP. The association between dietary patterns and the novel inflammatory markers platelet‐activating factor and lipoprotein‐associated phospholipase A2: a systematic review. Nutr Rev. 2022;80:1371‐1391.
Koelman L, Egea Rodrigues C, Aleksandrova K. Effects of dietary patterns on biomarkers of inflammation and immune responses: a systematic review and meta‐analysis of randomized controlled trials. Adv Nutr. 2022;13:101‐115.
Neale EP, Batterham MJ, Tapsell LC. Consumption of a healthy dietary pattern results in significant reductions in C‐reactive protein levels in adults: a meta‐analysis. Nutr Res. 2016;36:391‐401.
Wu PY, Chen KM, Tsai WC. The Mediterranean dietary pattern and inflammation in older adults: a systematic review and meta‐analysis. Adv Nutr. 2021;12:363‐373.
Craddock JC, Neale EP, Peoples GE, Probst YC. Vegetarian‐based dietary patterns and their relation with inflammatory and immune biomarkers: a systematic review and meta‐analysis. Adv Nutr. 2019;10:433‐451.
Huo R, Du T, Xu Y, et al. Effects of Mediterranean‐style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta‐analysis. Eur J Clin Nutr. 2015;69:1200‐1208.
Lee J, Jeon JY, Meyerhardt JA. Diet and lifestyle in survivors of colorectal cancer. Hematol Oncol Clin North Am. 2015;29:1‐27.
Van Blarigan EL, Meyerhardt JA. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol. 2015;33:1825‐1834.
Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021;71:333‐358.
Mayne ST, Playdon MC, Rock CL. Diet, nutrition, and cancer: past, present and future. Nat Rev Clin Oncol. 2016;13:504‐515.
Steck SE, Murphy EA. Dietary patterns and cancer risk. Nat Rev Cancer. 2020;20:125‐138.
Wade KH, Yarmolinsky J, Giovannucci E, et al. Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer. Cancer Causes Control. 2022;33:631‐652.
Aune D, Keum N, Giovannucci E, et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose‐response meta‐analysis of prospective studies. BMJ. 2016;353:i2716.
Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer. 1971;28:3‐13.
Um CY, Peters BA, Choi HS, et al. Grain, gluten, and dietary fiber intake influence gut microbial diversity: data from the food and microbiome longitudinal investigation. Cancer Res Commun. 2023;3:43‐53.
Gomes SD, Oliveira CS, Azevedo‐Silva J, et al. The role of diet related short‐chain fatty acids in colorectal cancer metabolism and survival: prevention and therapeutic implications. Curr Med Chem. 2020;27:4087‐4108.
Milesi G, Rangan A, Grafenauer S. Whole grain consumption and inflammatory markers: a systematic literature review of randomized control trials. Nutrients. 2022;14:374.
Sanders LM, Zhu Y, Wilcox ML, Koecher K, Maki KC. Whole grain intake, compared to refined grain, improves postprandial glycemia and insulinemia: a systematic review and meta‐analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021;5:1‐19.
Buldak RJ, Hejmo T, Osowski M, et al. The impact of coffee and its selected bioactive compounds on the development and progression of colorectal cancer in vivo and in vitro. Molecules. 2018;23:3309.
Halvorsen BL, Carlsen MH, Phillips KM, et al. Content of redox‐active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr. 2006;84:95‐135.
Kang NJ, Lee KW, Kim BH, et al. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis. 2011;32:921‐928.
Choi DW, Lim MS, Lee JW, et al. The cytotoxicity of kahweol in HT‐29 human colorectal cancer cells is mediated by apoptosis and suppression of heat shock protein 70 expression. Biomol Ther (Seoul). 2015;23:128‐133.
Kim HG, Hwang YP, Han EH, et al. The coffee diterpene kahweol inhibits metastasis by modulating expressions of MMPs and VEGF via STAT3 inactivation. Food Chem. 2012;133:1521‐1529.
Riihimaki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.
Epner M, Yang P, Wagner RW, Cohen L. Understanding the link between sugar and cancer: an examination of the preclinical and clinical evidence. Cancers (Basel). 2022;14:6042.
Debras C, Chazelas E, Srour B, et al. Artificial sweeteners and cancer risk: results from the NutriNet‐Sante population‐based cohort study. PLoS Med. 2022;19:e1003950.
Krishnan AV, Feldman D. Mechanisms of the anti‐cancer and anti‐inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311‐336.
van Harten‐Gerritsen AS, Balvers MG, Witkamp RF, Kampman E, van Duijnhoven FJ. Vitamin D, inflammation, and colorectal cancer progression: a review of mechanistic studies and future directions for epidemiological studies. Cancer Epidemiol Biomarkers Prev. 2015;24:1820‐1828.
Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther. 2016;15:17‐39.
Bours MJ, Beijer S, Winkels RM, et al. Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long‐Term Evaluation of Survivorship (PROFILES) registry. Br J Nutr. 2015;114:286‐296.
Savitz DA, Wellenius GA, Trikalinos TA. The problem with mechanistic risk of bias assessments in evidence synthesis of observational studies and a practical alternative: assessing the impact of specific sources of potential bias. Am J Epidemiol. 2019;188:1581‐1585.
Bonet C, Crous‐Bou M, Tsilidis KK, et al. The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study. Eur J Epidemiol. 2023;38:545‐557.
Carr PR, Jansen L, Walter V, et al. Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment. Am J Clin Nutr. 2016;103:192‐200.
Lewis CM, Wolf WA, Xun P, Sandler RS, He K. Racial differences in dietary changes and quality of life after a colorectal cancer diagnosis: a follow‐up of the study of outcomes in colorectal cancer survivors cohort. Am J Clin Nutr. 2016;103:1523‐1530.
Collaborators GBDCC. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7:627‐647.
Carethers JM, Doubeni CA. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology. 2020;158:354‐367.
Friedenreich CM, Shaw E, Neilson HK, Brenner DR. Epidemiology and biology of physical activity and cancer recurrence. J Mol Med (Berl). 2017;95:1029‐1041.
Spei ME, Bellos I, Samoli E, Benetou V. Post‐diagnosis dietary patterns among cancer survivors in relation to all‐cause mortality and cancer‐specific mortality: a systematic review and meta‐analysis of cohort studies. Nutrients. 2023;15:3860.
Demark‐Wahnefried W, Rogers LQ, Alfano CM, et al. Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin. 2015;65:167‐189.
Joseph R, Hart NH, Bradford N, et al. Diet and exercise advice and referrals for cancer survivors: an integrative review of medical and nursing perspectives. Support Care Cancer. 2022;30:8429‐8439.
Orsso CE, Ford KL, Kiss N, et al. Optimizing clinical nutrition research: the role of adaptive and pragmatic trials. Eur J Clin Nutr. 2023;77:1130‐1142.
Cross AJ, Gunter MJ. Coffee and colorectal cancer: grounds for prevention? Gastroenterology. 2018;154:790‐792.
Kim J, Lee HK. Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 2021;12:807648.